Intrinsic Value of S&P & Nasdaq Contact Us

Revvity, Inc. RVTY NYSE

NYSE • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
56/100
2/7 Pass
SharesGrow Intrinsic Value
$66.26
-29.1%
Analyst Price Target
$115.14
+23.1%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Revvity, Inc. (RVTY) trades at a trailing P/E of 41.4, forward P/E of 17.3. Trailing earnings yield is 2.42%, forward earnings yield 5.77%. PEG 0.11 (Peter Lynch undervalued ≤1.0). Graham Number is $55.46.

Criteria proven by this page:

  • VALUE (27/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 41.4).
  • Forward P/E 17.3 (down from trailing 41.4) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 0.11 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 2.42% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 5.77% as earnings recover.
  • Analyst consensus target $115.14 (+23.1% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 56/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
56/100
SG Score
View full scorecard →
VALUE
27/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
58/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
65/100
→ Income
GROWTH
15/100
→ Income
~
INCOME
45/100
→ Income

Valuation Snapshot — RVTY

Valuation Multiples
P/E (TTM)41.4
Forward P/E17.3
PEG Ratio0.11
Forward PEG0.11
P/B Ratio1.38
P/S Ratio3.46
EV/EBITDA16.3
Per Share Data
EPS (TTM)$2.13
Forward EPS (Est.)$5.40
Book Value / Share$64.04
Revenue / Share$25.23
FCF / Share$4.51
Yields & Fair Value
Earnings Yield2.42%
Forward Earnings Yield5.77%
Dividend Yield0.32%
Graham Number$55.46
SharesGrow IV$66.26 (-29.1%)
Analyst Target$115.14 (+23.1%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 24.4 1.87 2.65 2.70 0.54%
2017 71.8 -1.39 3.24 3.60 0.38%
2018 36.4 0.33 3.36 3.13 0.36%
2019 47.3 -9.59 3.82 3.73 0.29%
2020 22.0 0.10 4.28 4.23 0.20%
2021 24.8 1.02 3.27 6.10 0.14%
2022 31.1 -0.70 2.40 5.34 0.20%
2023 -115.2 0.95 1.73 4.96 0.26%
2024 46.2 -0.13 1.78 4.96 0.25%
2025 45.5 -3.32 1.52 3.85 0.30%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $2.12 $2.12B $234.3M 11.1%
2017 $1.42 $2.26B $156.89M 7%
2018 $2.13 $2.78B $237.93M 8.6%
2019 $2.04 $2.88B $227.56M 7.9%
2020 $6.49 $2.66B $727.89M 27.3%
2021 $8.08 $3.83B $943.16M 24.6%
2022 $4.50 $3.31B $569.18M 17.2%
2023 $5.55 $2.75B $693.09M 25.2%
2024 $2.20 $2.76B $270.39M 9.8%
2025 $2.08 $2.86B $241.68M 8.5%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $5.40 $5.36 – $5.45 $2.98B $2.97B – $3B 10
2027 $5.98 $5.84 – $6.19 $3.13B $3.09B – $3.16B 10
2028 $6.53 $5.31 – $7.75 $3.3B $3.28B – $3.31B 2
2029 $7.16 $7.09 – $7.25 $3.48B $3.46B – $3.52B 1
2030 $7.91 $7.83 – $8.01 $3.69B $3.66B – $3.72B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message